By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bayer’s New Twist on Aspirin–Fast Acting Advanced Formula
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Bayer’s New Twist on Aspirin–Fast Acting Advanced Formula
Business

Bayer’s New Twist on Aspirin–Fast Acting Advanced Formula

BarbaraDuck
BarbaraDuck
Share
4 Min Read
SHARE

If you are not getting fast enough relief, here’s a chance to get faster relief as the web page states.  Maybe this is why Johnson and Johnson sold off their aspirin as maybe it wasn’t fast enough:)  It is supposed to enter your bloodstream and offer relief 6 times faster than normal aspirin.  I guess when I go to the drug store next time I can compare and see how much difference there is in the price.  Bottom line is that the product has a new molecule that allows this to occur, or as the website states, “it gushes” to relieve the pain.  The video below is kind of

If you are not getting fast enough relief, here’s a chance to get faster relief as the web page states.  Maybe this is why Johnson and Johnson sold off their aspirin as maybe it wasn’t fast enough:)  It is supposed to enter your bloodstream and offer relief 6 times faster than normal aspirin.  I guess when I go to the drug store next time I can compare and see how much difference there is in the price.  Bottom line is that the product has a new molecule that allows this to occur, or as the website states, “it gushes” to relieve the pain.  The video below is kind of interesting as you get to see the aspirin factory in motion.  BD   

Johnson & Johnson Sells Off St. Joseph’s Aspirin to llex–Too Many Recalls

MORRISTOWN, NJ, May 23, 2011 /PRNewswire/ — Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets*.

With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer’s overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.

A national survey of American consumers found that 44 percent of respondents suffered from acute pain in the previous two weeks¹. If extrapolated to the U.S. population, this would equate to approximately 45 million adults². Active men and women can’t afford to be sidelined with pain. Faster pain relief can help get them back to their busy lives. Bayer Advanced Aspirin was developed with the objective of providing a faster onset of pain relief than previous Bayer Aspirin tablets giving consumers a new and better aspirin for tough pain.

Bayer Advanced Aspirin is now available at major retailers nationwide in Regular and Extra Strength doses at 325 mg and 500 mg.

BAYER HEALTHCARE LAUNCHES THE NEXT GENERATION OF ASPIRIN FOR PAIN RELIEF – CLINICALLY PROVEN TO RELIEVE PAIN TWICE AS FAST AS BEFORE*

 

More Read

Is Europe A Better Place To Build A Medical Technology Company?
Why Massachusetts Can Afford Universal Health Insurance
What Healthcare Will Look Like Five Years From Today
The PCMH and Home Care Data: An Interview with Melissa McCormack
Conflict of Interest Problems in Xigris Marketing

TAGGED:aspirinBayerhealth care business
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

language barriers in healthcare
Language Barriers Are Most Underestimated Risk in Healthcare
Global Healthcare Policy & Law
March 29, 2026
nurse checking her schedule
Managing On-Call Lists for Healthcare Open Shifts
Health
March 26, 2026
outdoor yoga class in sunny park setting
Resveratrol Capsules VS Resveratrol Powder: Are There Differences?
Health
March 26, 2026
Clinical Trials Demystified: Yousuf A. Gaffar, M.D’s Guide to Research and Patient Impact
Clinical Trials Demystified: Yousuf A. Gaffar, M.D’s Guide to Research and Patient Impact
Health
March 25, 2026

You Might also Like

Ebola
BusinessNewsPublic Health

The Technology Corner: 3 Companies That Could Eradicate Ebola Virus

April 25, 2012

Nurses Hold One Day Strike at Kaiser’s Sunset Boulevard Medical Center (Los Angeles) To Bring Attention To Patient Safety

March 2, 2011
obamacare an covered california
BusinessFinanceHealth ReformPolicy & LawPublic Health

Obamacare and Reimbursement Rates to Providers

December 11, 2013
BusinessHealth Reform

Value-based care: can we get there with current tools?

February 19, 2016
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?